We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
-6.09%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$58.1B
AUM Growth
-$4.3B
(-6.9%)
Cap. Flow
-$734M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,548
New
92
Increased
523
Reduced
773
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Telus
TU
|
+$198M |
| 2 |
Synopsys
SNPS
|
+$173M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$142M |
| 4 |
Intuitive Surgical
ISRG
|
+$111M |
| 5 |
Bank of Montreal
BMO
|
+$95.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$404M |
| 2 |
Thomson Reuters
TRI
|
+$171M |
| 3 |
Scotiabank
BNS
|
+$115M |
| 4 |
Adobe
ADBE
|
+$103M |
| 5 |
Suncor Energy
SU
|
+$81.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.66% |
| 2 | Technology | 16.56% |
| 3 | Industrials | 12.04% |
| 4 | Healthcare | 10.68% |
| 5 | Energy | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Organon & Co
OGN
$3.56B
| $292K | ﹤0.01% |
12,459
+5,493
| +79% | +$166K |
|
1102
Scholastic
SCHL
$794M
| $292K | ﹤0.01% |
9,500
-120
| -1% | -$5K |
|
1103
Rapid7
RPD
$680M
| $291K | ﹤0.01% |
6,772
-42,626
| -86% | -$2.63M |
|
1104
United Bankshares
UBSI
$6.7B
| $291K | ﹤0.01% |
8,138
-1,025
| -11% | -$38.2K |
|
|
STOR
1105
DELISTED
STORE Capital Corporation
STOR
| $290K | ﹤0.01% |
+9,257
| New | +$263K |
|
1106
Bloomin' Brands
BLMN
$774M
| $289K | ﹤0.01% |
+15,788
| New | +$314K |
|
|
DEN
1107
DELISTED
Denbury Inc.
DEN
| $289K | ﹤0.01% |
3,352
-114
| -3% | -$8.74K |
|
|
DMC
1108
Del Monte Corp
DMC
$1.43B
| $286K | ﹤0.01% |
12,311
-314
| -2% | -$8.75K |
|
1109
Alarm.com
ALRM
$2.75B
| $284K | ﹤0.01% |
4,377
+25
| +0.6% | +$1.72K |
|
1110
World Kinect Corp
WKC
$2B
| $284K | ﹤0.01% |
12,137
+1,759
| +17% | +$43.6K |
|
|
PGRE
1111
DELISTED
Paramount Group
PGRE
| $283K | ﹤0.01% |
45,484
-5,684
| -11% | -$40.9K |
|
1112
Cerus
CERS
$433M
| $282K | ﹤0.01% |
78,240
-384
| -0.5% | -$1.84K |
|
1113
Insight Enterprises
NSIT
$3.98B
| $281K | ﹤0.01% |
3,413
-85
| -2% | -$7.56K |
|
1114
Corcept Therapeutics
CORT
$12.2B
| $280K | ﹤0.01% |
+10,931
| New | +$293K |
|
1115
Teva Pharmaceuticals
TEVA
$40.2B
| $280K | ﹤0.01% |
34,669
| – | – |
|
1116
McGrath RentCorp
MGRC
$2.92B
| $279K | ﹤0.01% |
3,324
-163
| -5% | -$13.5K |
|
1117
Applied Industrial Technologies
AIT
$13B
| $278K | ﹤0.01% |
2,704
-142
| -5% | -$14.6K |
|
1118
Home BancShares
HOMB
$6.27B
| $277K | ﹤0.01% |
12,303
-649
| -5% | -$15.1K |
|
|
LNW
1119
DELISTED
Light & Wonder
LNW
| $277K | ﹤0.01% |
6,456
-232
| -3% | -$11.5K |
|
|
GBT
1120
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $277K | ﹤0.01% |
+4,061
| New | +$224K |
|
1121
Commercial Metals
CMC
$7.77B
| $276K | ﹤0.01% |
7,789
-210
| -3% | -$8.11K |
|
|
PCH
1122
DELISTED
PotlatchDeltic
PCH
| $276K | ﹤0.01% |
6,735
-1,474
| -18% | -$67.7K |
|
|
ITCI
1123
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $276K | ﹤0.01% |
5,941
-50,989
| -90% | -$2.66M |
|
1124
New Jersey Resources
NJR
$5.86B
| $275K | ﹤0.01% |
7,114
-304
| -4% | -$13.6K |
|
1125
Intellia Therapeutics
NTLA
$1.5B
| $275K | ﹤0.01% |
4,922
-264
| -5% | -$16.4K |
|
Similar funds
Mackenzie Financial's Q3 2022 Portfolio in Review
As of Q3 2022, Mackenzie Financial held 1,548 positions worth $58.1B, down 6.9% from $62.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Mackenzie Financial's Q3 2022 filing shows 92 new, 523 increased, 773 reduced and 123 closed positions. Its largest new stake was PBF Energy: 296,541 shares worth $10.4M. The largest sale was Stryker, an estimated $404M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q3 2022 buy was PBF Energy: 296,541 shares worth $10.4M.
- Mackenzie Financial added most to Telus in Q3 2022, an estimated $198M increase.
- Mackenzie Financial's biggest Q3 2022 reduction was Stryker, cutting an estimated $404M.
- Mackenzie Financial fully exited Brunswick in Q3 2022, selling an estimated $30.5M.
- Mackenzie Financial's ten largest holdings make up 23% of its $58.1B portfolio in Q3 2022.
- Mackenzie Financial opened 92 new positions and closed 123 in Q3 2022.
- Mackenzie Financial's portfolio value fell 6.9% quarter-over-quarter to $58.1B.
Based on Mackenzie Financial's 13F filing for Q3 2022, filed 7 Oct 2022.